Demierre MF, Chung C, Miller DR, et al.- Early detection of thick melanomas in the United States : beware of the nodular subtype. Arch Dermatol, 2005, 141, 745-750. (Pubitemid 41001075)
Geller AC, Swetter SM, Brooks K, et al.- Screening, early detection, and trends for melanoma : current satus (2000-2006) and future directions. J Am Acad Dermatol, 2007, 57, 555-572. (Pubitemid 47384936)
MacKie RM, Bray C, Vestey J, et al.- Melanoma incidence and mortality in Scotland 1979-2003. Br J Cancer, 2007, 96, 1772-1777. (Pubitemid 46847216)
Bourguignon R, Giet-Lesuisse M, Arrese JE, et al.- Mélanome à croissance rapide. Rev Med Liège, 2009, 64, 429-431.
Grob JJ, Richard MA, Gouvernet J, et al.- The kinetics of the visible growth of a primary melanoma reflects the tumor aggressiveness and is an independent prognostic marker : a prospective study. Int J Cancer, 2002, 102, 34-38.
Liu W, Dowling JP, Murray WK, et al.- Rate of growth in melanomas : characteristics and associations of rapidly growing melanomas. Arch Dermatol 2006, 142, 1551-1558. (Pubitemid 44969210)
Piérard-Franchimont C, Arrese JE, Quatresooz P, et al.- Mini-mélanome papulo-achromique de croissance rapide. Dermatol Actual, 2009, 114, 8-10.
Quatresooz P, Piérard-Franchimont C, Paquet P, et al.- Angiogenic fast-growing melanomas and their micrometastases. Eur J Dermatol, 2010, 20, 302-307.
Azzola MF, Shaw HM, Thompson JF, et al.- Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an analysis of 3661 patients from a single center. Cancer, 2003, 97, 1488-1498. (Pubitemid 36297779)
Quatresooz P, Arrese JE, Piérard-Franchimont C, et al.- Immunohistochemical aid at risk stratification of melanocytic neoplasms. Int J Oncol, 2004, 24, 211-216.
Nagore E, Oliver V, Botella-Estrada R, et al.- Prognostic factors in localized invasive cutaneous melanoma : high value of mitotic rate, vascular invasion and microscopic satellitosis. Melanoma Res, 2005, 15, 169-177. (Pubitemid 40839464)
Vereecken P, Laporte M, Heenen M.- Significance of cell kinetic parameters in the prognosis of malignant melanoma : a review. J Cutan Pathol, 2007, 3, 139-145. (Pubitemid 46145553)
Balch CM, Gershenwald JE, Soong SJ, et al.- Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol, 2009, 27, 6199-6206.
Quatresooz P, Piérard GE, Piérard-Franchimont C, et al.- Molecular pathways supporting the proliferation staging of malignant melanoma. Int J Mol Med, 2009, 24, 295-301.
Piérard GE, Piérard-Franchimont C, The Mosan Study Group of Pigmented Tumors.- Malignant melanoma and its growth fraction. In : Trends in dermatology research. roth DE (ed). Nova Science, 2010, 259-268.
Rappa G, Fodstad O, Lorico A.- The stem cell-associated antigen CD113 (Prominin-1) is a molecular therapeutic target for metastatic melanoma. Stem Cells, 2008, 26, 3008-3017.
Schatton T, Murphy GF, Frank NY, et al.- Identification of cells initiating human melanomas. Nature, 2008, 451, 345-349.
